Naptumomab是一種融合蛋白,由單克隆抗體的抗原結(jié)合片段(Fab)與超抗原葡萄球菌腸毒素A(SEA/E-120,“依他芬那妥”)組成。Fab與各種腫瘤細(xì)胞表達(dá)的抗原5 T4結(jié)合,超抗原通過活化T淋巴細(xì)胞誘導(dǎo)免疫應(yīng)答。 Naptumomab生物仿制藥-研究級(jí)該產(chǎn)品同種型對(duì)照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.